Aspect Biosystems

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$115M

Aspect Biosystems develops bioprinted tissue therapeutics to treat serious metabolic and endocrine diseases using AI-powered bioprinting technology.